跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROGRAF XL tacrolimus 3 mg prolonged-release capsules blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PROGRAF XL tacrolimus 3 mg prolonged-release capsules blister pack
Approved
STANDARD
PROGRAF XL tacrolimus 3 mg prolonged-release capsules blister pack
Astellas Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d72f162eb2f67575
Company
Astellas Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d72f162eb2f67575
Product Name
PROGRAF XL tacrolimus 3 mg prolonged-release capsules blister pack
Artg Id
306500
Artg Name
PROGRAF XL tacrolimus 3 mg prolonged-release capsules blister pack
Sponsor
Astellas Pharma Australia Pty Ltd
Company Detail Path
/organization/astellas-pharma-australia-pty-ltd
Artg Date
2019-07-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d72f162eb2f67575
Type
Standard
Back to TGA Approvals
